Beximco Pharma Denies Corruption Allegations in Vaccine Procurement

Beximco Pharmaceuticals Limited Sponsored GDR RegS ( (GB:BXP) ) just unveiled an announcement.

Beximco Pharmaceuticals Limited has refuted allegations of corruption in the Covid-19 vaccine procurement process, which have been circulating in Bangladesh media. The company clarified its role as an intermediary in the procurement of 15 million doses of the Covishield vaccine from the Serum Institute of India, emphasizing that it acted with full regulatory compliance and transparency. The allegations, which suggest mismanagement of government funds and bypassing of procurement rules, have been described by Beximco as baseless and part of a smear campaign. The company is considering legal action against the defamatory reports and remains committed to maintaining its reputation and transparency.

More about Beximco Pharmaceuticals Limited Sponsored GDR RegS

Beximco Pharmaceuticals Limited is a rapidly growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients. The company is a significant player in the pharmaceutical industry, known for its global footprint in over 60 countries and being the largest exporter of medicines in Bangladesh. It has been recognized for its innovation and contribution to the economy, having won the National Export Trophy (Gold) nine times.

YTD Price Performance: -2.56%

Average Trading Volume: 34,883

Technical Sentiment Consensus Rating: Hold

Learn more about BXP stock on TipRanks’ Stock Analysis page.